Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Adult Joint Formulary

6. Endocrine system Guidelines

Diabetes

Management

BNSSG Blood Glucose Management in Type 2 Diabetes

Blood Glucose Monitoring

Clinical Pathway for the use of diabetes technologies in all patients with Type 1 Diabetes

BNSSG Type 1 Blood Glucose Monitoring Guidance (Primary Care) (undergoing review, update expected early 2023)

BNSSG Type 2 Diabetes Blood Glucose Monitoring Guidance (Adults) 

Information on Continuous Glucose Monitoring (CGM) in Type 1 Diabetes for Primary Care

Dexcom One Ordering Information for Community Pharmacies

Insulin

BNSSG Pen Needles Guidance  

SGLT-2 inhibitors

Advice on the use of SGLT-2 inhibitors in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease

Osteoporosis

When to start Osteoporosis Treatment 2022 minor amendment

Osteoporosis - oral treatment duration, denosumab and drug holiday guidance 2021

BNSSG Osteoporosis Clinic Referral Guidance for GPs 2021

Bisphosphonate Drug Holiday Algorithm June 2021

Denosumab Drug Holiday Algorithm June 2021

 

Hormone Therapy for Gender Reassignment

Local Guidance

Guidance from Gender Identity Clinics (GIC) Clinics 

 

Menopause

BNSSG Menopause Guidelines and HRT Prescribing Pathway (updated July 2022)

 

Corticosteroids

Guidance on issuing the Steroid Emergency Card in adults

BNSSG Tool on Implementing the NPSA alert on the Emergency steroid card

For information regarding provision of a Steroid Emergency card for paediatrics, please see Paediatric Chapter 6.2 for further details